The neuroleptic malignant syndrome-a systematic case series analysis focusing on therapy regimes and outcome.

Kuhlwilm, L; Schönfeldt-Lecuona, C; Gahr, M; Connemann, B J; Keller, F; Sartorius, A

Kuhlwilm, L; Schönfeldt-Lecuona, C; Gahr, M; Connemann, B J; Keller, F; Sartorius, A.

Afiliación

Kuhlwilm L; Department of Psychiatry and Psychotherapy III, University Clinic Ulm, Ulm, Germany.
Schönfeldt-Lecuona C; Department of Psychiatry and Psychotherapy III, University Clinic Ulm, Ulm, Germany.
Gahr M; Department of Psychiatry and Psychotherapy III, University Clinic Ulm, Ulm, Germany.
Connemann BJ; Department of Psychiatry and Psychotherapy III, University Clinic Ulm, Ulm, Germany.
Keller F; Department of Child and Adolescent Psychiatry and Psychotherapy, University of Ulm, Ulm, Germany.
Sartorius A; Department of Psychiatry and Psychotherapy, Central Institute of Mental Health (CIMH), Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.

Acta Psychiatr Scand ; 142(3): 233-241, 2020 09.

Article en En | MEDLINE | ID: mdl-32659853

Asunto(s)

Antipsicóticos; Terapia Electroconvulsiva; Síndrome Neuroléptico Maligno; Dantroleno/uso terapéutico; Humanos; Síndrome Neuroléptico Maligno/tratamiento farmacológico; Síndrome Neuroléptico Maligno/etiología

Palabras clave

antipsychotics; neuroleptic malignant syndrome; therapy; treatment

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Antipsicóticos / Terapia Electroconvulsiva / Síndrome Neuroléptico Maligno Tipo de estudio: Etiology_studies Idioma: En Revista: Acta Psychiatr Scand Año: 2020 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google